Tanan Bejrananda
Overview
Explore the profile of Tanan Bejrananda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Economic Evaluation of Robotic-assisted Radical Prostatectomy: A Systematic Review and Meta-analysis
Bejrananda T, Khaing W, Veettil S, Thongseiratch T, Chaiyakunapruk N
Eur Urol Open Sci
. 2025 Feb;
72:17-28.
PMID: 39996029
Background And Objective: Robotic-assisted radical prostatectomy (RARP) is a surgical option for localized prostate cancer. Cost-effectiveness analysis (CEA) findings are inconsistent when comparing it with open (ORP) and laparoscopic (LRP)...
2.
Bejrananda T, Takahara K, Sowanthip D, Motonaga T, Yagi K, Nakamura W, et al.
Sci Rep
. 2025 Jan;
15(1):2079.
PMID: 39814834
Prostate cancer (PCa) is one of the most common cancers among men worldwide, and robot-assisted radical prostatectomy (RARP) is a widely used treatment for localized PCa. Achieving pentafecta outcomes, which...
3.
Bejrananda T, Takahara K, Sowanthip D, Motonaga T, Yagi K, Nakamura W, et al.
Heliyon
. 2025 Jan;
11(1):e41031.
PMID: 39758412
Objective: This study aimed to establish a robust predictive model for biochemical recurrence (BCR) in patients with prostate cancer who underwent robot-Assisted Radical Prostatectomy. Material And Methods: A cohort of...
4.
Thongseiratch T, Chandeying N, Bejrananda T
Med Educ
. 2024 Nov;
59(2):230-231.
PMID: 39543933
No abstract available.
5.
Bejrananda T, Pinkheaw N, Sathitruangsak C, Tanthanuch M
Clin Genitourin Cancer
. 2024 May;
22(4):102117.
PMID: 38820999
Objective: This study aimed to investigate disease-free survival (DFS) outcomes and associated prognostic factors among surgically treated penile cancer patients at Songklanagarind Hospital, Thailand, over a 20-year period. Methods: A...
6.
Sowanthip D, Zennami K, Bejrananda T, Nukaya T, Takenaka M, Ichino M, et al.
Int J Urol
. 2024 Jan;
31(4):370-378.
PMID: 38180102
Objective: To evaluate the safety and efficacy of robot-assisted radical cystectomy using an intracorporeal ileal conduit in older compared to younger patients. Methods: We retrospectively analyzed 122 patients who underwent...
7.
Bejrananda T, Jakjaroenrit N
IJU Case Rep
. 2024 Jan;
7(1):56-59.
PMID: 38173452
Background: Schwannomas originating in the prostate are extremely rare. We present a case of prostatic schwannoma in a 66-year-old male with lower urinary tract symptoms. Preoperative evaluation revealed a prostatic...
8.
Bejrananda T, Pliensiri P
BMC Urol
. 2023 Nov;
23(1):183.
PMID: 37953250
Background: Radical prostatectomy (RP) has been considered primary treatment for localized prostate cancer. Biochemical recurrence (BCR) occur approximately 20-30% in five year after RP. We aim to develop a novel...
9.
Pinkheaw N, Sathitruangsak C, Tanthanuch M, Bejrananda T
Int J Urol
. 2023 Oct;
31(2):144-153.
PMID: 37846171
Objective: This study investigated disease-free survival and oncological outcomes in penile cancer patients treated surgically at a high-volume center and identified the prognostic factors for disease-free survival. Methods: A retrospective...
10.
Bejrananda T, Takahara K, Sowanthip D, Motonaga T, Yagi K, Nakamura W, et al.
Sci Rep
. 2023 Sep;
13(1):15835.
PMID: 37740045
Pentafecta (continence, potency, cancer control, free surgical margins, and no complications) is an important outcome of prostatectomy. Our objective was to assess the pentafecta achievement between nerve-spring and non-nerve-sparing robot-assisted...